CIK 0002093101 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-09 | 8-K/A | 8-K/A items 8.01 | 2026-10-07 |
| 2026-10-08 | 8-K | 8-K items 1.01,3.02,8.01,9.01 | 2026-10-07 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-13 | 8-K | 8-K items 2.02,9.01 | 2026-08-13 |
| 2026-07-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-14 | 8-K | 8-K items 8.01,9.01 | 2026-07-14 |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-14 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-14 | 8-K | 8-K items 2.02,9.01 | 2026-05-14 |
| 2026-04-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-22 | 4 | 4 | 2026-04-20 |
| 2026-04-22 | 4 | 4 | 2026-04-20 |
| 2026-04-22 | 4 | 4 | 2026-04-20 |
| 2026-04-22 | 4 | 4 | 2026-04-20 |
Forms on file (last 1,000): 4 19, 3 11, 8-K 6, SCHEDULE 13G 4, SCHEDULE 13G/A 3, 10-Q 2, S-8 2, 10-12B/A 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=RNA (0.002 USD), /gw/filings/filings?ticker=RNA&form=8-K, /gw/filings/facts?ticker=RNA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange